Stay updated on Amifampridine in MuSK-MG Clinical Trial
Sign up to get notified when there's something new on the Amifampridine in MuSK-MG Clinical Trial page.

Latest updates to the Amifampridine in MuSK-MG Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference4%
- Check16 days agoChange DetectedAdded a new version label (v3.1.0) and removed several safety-focused topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs), indicating a shift in page scope away from those subjects.SummaryDifference0.5%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, indicating a new release; the 'Back to Top' navigation element has been removed, a minor UI change with no substantive content updates.SummaryDifference0.2%
- Check38 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check45 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as new content related to drug safety and specific pharmaceutical compounds. Notably, terms related to Myasthenia gravis and Amifampridine have been removed.SummaryDifference3%
- Check59 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.1%
Stay in the know with updates to Amifampridine in MuSK-MG Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amifampridine in MuSK-MG Clinical Trial page.